Abstract:Background Trophinin-associated protein (TROAP), a cytoplasmic protein, is essential for microtubule cytoskeleton assembly. Mounting evidence demonstrates the vital role of TROAP in regulating the proliferation and migration of cells, but it is unclear how it contributes to cancer progression. Methods The online portals of GEPIA2, Cancer Cell Line Encyclopedia, UALCAN, Human Protein Atlas, and PrognoScan were used to analyze TROAP expression in various tumors and further evaluate its correlation with prognosis. With Western blot and quantitative real-time PCR analysis, we validated TROAP expression levels in hepatocellular carcinoma (HCC) and colorectal cancer (CRC). Ten pairs of HCC and CRC tissues were selected for immunohistochemistry to determine TROAP expression levels in tumors and adjacent tissues, respectively. TROAP knockdown in CRC and HCC cells to verify its role in malignant phenotypes. The genomic and post-transcriptional alterations of TROAP in tumors were determined using the cBioPortal and SangerBox databases. Also, TISIDB was used to investigate the relationship between TROAP expression and tumor microenvironment(TME) among different cancer types. Moreover, a correlation was found between the expression of TROAP and drug sensitivity using GSCALite and CellMiner databases. Results TROAP expression was significantly upregulated in most cancer types, which is consistent with our validated experimental results in HCC and CRC cells, and immunohistochemistry results. And a poor prognosis was linked to TROAP aberrant expression. Our findings indicated that malignant phenotypes and tumorigenesis induced by TROAP could be due to an activation of the PI3K/Akt/GSK-3β signaling pathway. Furthermore, we found a correlation between TROAP expression and genomic and post-transcriptional alterations in various tumors, including tumor mutation burden, and microsatellite instability. Next, we demonstrated that TROAP expression was associated with the infiltration of immune cells, such as neutrophils and macrophages, and correlated with immunomodulation-related genes in the TME. Additionally, the potential role of TROAP expression in predicting the sensitivity of drugs, including melphalan and chlorambucil, was demonstrated. Conclusions Collectively, these findings indicated a significant correlation between TROAP expression and malignant phenotype, functional mechanism, survival possibility, TME, therapeutic potential, and prediction of drug sensitivity in various cancers. Hence, TROAP is a promising biomarker and therapeutic target for predicting cancer outcomes.

TROAP Promotes Breast Cancer Proliferation and Metastasis

High Trophinin‑Associated Protein Expression and Its Role in Prognosis of Pancreatic Cancer

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers

TROAP Regulates Prostate Cancer Progression Via the WNT3/survivin Signalling Pathways

TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3

ASPM and TROAP gene expression as potential malignant tumor markers

Integrative Analysis of TROAP with Molecular Features, Carcinogenesis, and Related Immune and Pharmacogenomic Characteristics in Soft Tissue Sarcoma

High Trophinin-Associated Protein Expression is an Independent Predictor of Poor Survival in Liver Cancer

EZH2-TROAP Pathway Promotes Prostate Cancer Progression Via TWIST Signals

METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway

Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma

Overexpression of Tmprss4 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer

High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics

Identification of biomarker associated with Trop2 in breast cancer: implication for targeted therapy

Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.

Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA

Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer

Activator Protein-2β Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer

BRCA1-associated protein induced proliferation and migration of gastric cancer cells through MAPK pathway.

Overexpression of TROP2 Promotes Proliferation and Invasion of Ovarian Cancer Cells

LncRNA TROJAN Promotes Proliferation and Resistance to CDK4/6 Inhibitor Via CDK2 Transcriptional Activation in ER+ Breast Cancer.